Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Ipsen Inc patents


Recent patent applications related to Ipsen Inc. Ipsen Inc is listed as an Agent/Assignee. Note: Ipsen Inc may have other listings under different names/spellings. We're not affiliated with Ipsen Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Ipsen Inc-related inventors


Melanocortin receptor ligands modified with hydantoin

The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.. . ... Ipsen Inc

Manufacture of recombinant clostridium botulinum neurotoxins

The invention provides methods for producing soluble di-chain bont/a protein.. . ... Ipsen Inc

Combination therapy for cancer treatment

Combination therapies for treating cancer comprising administration of a topoisomerase-1 inhibitor and a parp inhibitor are provided. The topoisomerase-1 inhibitor can be delivered as a liposomal formulation that provides for prolonged accumulation of the topoisomerase-1 inhibitor within a tumor relative to outside of the tumor. ... Ipsen Inc

Ipsen Pharma S.a.s.

. . ... Ipsen Inc

Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin

Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of pancreatic cancer, including treatment of patients diagnosed with previously untreated metastatic adenocarcinoma of the pancreas. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.. ... Ipsen Inc

Chmeric polypeptides

The invention relates to recombinant clostridial neurotoxins which have been modified to improve their activation. In particular, the present invention relates to chimeric clostridial neurotoxins in which the activation loop has been replaced by the activation loop from a different subtype within the same serotype. ... Ipsen Inc

Combination of tasquinimod or a pharmaceutically acceptable salt thereof and a pd-1 and/or pd-l1 inhibitor, for use as a medicament

The present invention concerns a combination comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and a pd-1 and/or pd-l1 inhibitor, for use as a medicament. It also concerns a pharmaceutical composition comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and pd-1 and/or pd-l1 inhibitor.. ... Ipsen Inc

Methods for treating pancreatic cancer using combination therapies

Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (mm-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (mm-398) is co-administered with 5-fluorouracil and leucovorin.. ... Ipsen Inc

Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (mm-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (mm-398) is co-administered with 5-fluorouracil and leucovorin.. ... Ipsen Inc

Ipsen Pharma S.a.s.

. . ... Ipsen Inc

Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose

Solid and liquid pharmaceutical compositions comprising botulinum neurotoxin complex or high purity botulinum neurotoxin and a surfactant. The composition may comprise a crystalline agent.. ... Ipsen Inc

Liposomes useful for drug delivery

The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging entity. The present invention also provide methods of making the liposome compositions provided by the present invention.. ... Ipsen Inc

Ipsen Biopharm Ltd.

. . ... Ipsen Inc

Stabilizing camptothecin pharmaceutical compositions

Irinotecan phospholipid liposomes with improved storage stability are provided, with related methods of treatment and manufacture. The irinotecan liposomes can have reduced formation of lyso-phosphatidylcholine (lyso-pc) during storage, and prior to administration to a patient.. ... Ipsen Inc

10/26/17 / #20170304403

Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue

The present invention provides a method of ameliorating inflammation, inhibiting proinflammatory cytokine and/or chemokine expression and treating various diseases and/or conditions incidental to the onset of inflammation, in a subject in need of treatment for such conditions, by administering select analogues of native hghrelin.. . ... Ipsen Inc

09/28/17 / #20170275607

Carrier for targeting nerve cells

The present invention relates to a transport protein which can be obtained by modifying the heavy chain of the neurotoxin formed by clostridium botulinum wherein (i) the protein binds specifically to nerve cells with a higher or lower affinity as the native neurotoxin; (ii) the protein has an increased or reduced neurotoxicity compared to the native neurotoxin, the neurotoxicity being preferably determined in the hemidiaphragm assay; and/or (iii) the protein comprises a lower affinity against neutralizing antibodies compared to the native neurotoxin. The invention also relates to methods for producing the same and the use thereof in cosmetic and pharmaceutical compositions.. ... Ipsen Inc

08/24/17 / #the present invention is directed to compounds according to formula,

Ipsen Pharma S.a.s.

. . ... Ipsen Inc

08/24/17 / #20170240565

Macrocyclic lrrk2 kinase inhibitors

The present invention relates to novel macrocyclic compounds of formula (i) and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of lrrk2 (leucine-rich repeat kinase 2). Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine or diagnostic agent, in particular for the treatment and/or diagnosis of diseases characterized by lrrk2 kinase activity such as neurological disorders including parkinson's disease and alzheimer's disease.. ... Ipsen Inc

05/18/17 / #20170137489

Process for the synthesis of therapeutic peptides

A process for the large-scale synthesis of a therapeutic peptide using solid-phase fmoc-chemistry.. . ... Ipsen Inc

03/16/17 / #20170074589

System and method for facilitating the maintenance of an industrial furnace

A system and method for facilitating the maintenance of an industrial heat treating furnace are disclosed.. . ... Ipsen Inc

02/09/17 / #20170037104

Composition and methods for stimulating gastrointestinal motility

The present invention relates to a method of treating a transient impairment of the motility of the gastrointestinal system resulting from postoperative ileus in a patient wherein said method includes the step of administering a therapeutically effective amount of a peptidyl analog of ghrelin to said patient.. . ... Ipsen Inc

02/09/17 / #20170035884

Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release

An aqueous pharmaceutical composition comprising a peptide and one or more water-soluble or water-dispersible gelling agents.. . ... Ipsen Inc

01/05/17 / #the present invention relates to new biphenyl derivatives of formula







ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ipsen Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ipsen Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###